DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
85. 特発性間質性肺炎
Idiopathic interstitial pneumonia
Clinical trials
/
Disease details
臨床試験数
:
627
/
薬物数
:
443
- (
DrugBank
:
120
) /
標的遺伝子数
:
99
-
標的パスウェイ数
:
212
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT05428150
(
ClinicalTrials.gov
)
August 8, 2022
15/6/2022
Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers
Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet ...
Randomized, Crossover, Multi-Dose, Steady State, Comparative Pharmacokinetics and Relative Bioavailability Study of EXCL-100 Pirfenidone-Sustained Release Tablet (EXCL-100), and Esbriet® in Healthy Volunteers
Randomized, Crossover, Multi-Dose, Steady State, Comparative Pharmacokinetics and Relative Bioavaila ...
Idiopathic Pulmonary Fibrosis
Drug:
Esbriet
267 MG Oral Capsule
;Drug:
EXCL-100, 600 MG Oral Tablet
Excalibur Pharmaceuticals, Inc.
NULL
Completed
18 Years
65 Years
All
32
Phase 1
United States